Status:
COMPLETED
In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Cell Function
Eligibility:
All Genders
18+ years
Brief Summary
Peripheral blood mononuclear cells (PBMC) will be collected from healthy volunteers and patients who present with different diseases that involve or implicate the immune system dysregulation (HIV infe...
Detailed Description
Peripheral blood mononuclear cells (PBMC) will be collected from healthy volunteers and patients who present with different diseases that involve or implicate the immune system dysregulation (HIV infe...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Greater than or equal to 18 years old.
- Documented HIV infection by current DoD criteria (1 ELISA, 2 Confirmatory Western Blot) or by one of the following tests; DNA PCR, RNA PCR, p24 antigen test, viral culture assay.
- CD4 lymphocyte cell count greater than 300 mm(3).
- EXCLUSION CRITERIA:
- Unable to provide informed consent.
- Unable to meet the minimum (150 days) and maximum (395 days) research visit interval requirements.
Exclusion
Key Trial Info
Start Date :
April 12 1993
Trial Type :
OBSERVATIONAL
End Date :
March 3 2008
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT00342485
Start Date
April 12 1993
End Date
March 3 2008
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Willford Hall USAF Medical Center
San Antonio, Texas, United States, 78236